Compare Advance Auto Parts, Inc. (AAP) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Advance Auto Parts, Inc. vs Cronos Group Inc — how do they compare? Advance Auto Parts, Inc. trades at $53.1 (market cap $3.19B), while Cronos Group Inc trades at $3.08 (market cap $1.14B). The key difference: Advance Auto Parts, Inc. is far larger — about 2.8× Cronos Group Inc's market cap, and Advance Auto Parts, Inc. pays a 1.89% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| AAP | CRON | |
|---|---|---|
Market Cap | $3.19B | $1.14B |
Sector | Consumer Cyclical | Health |
52-Week High | $64.17 | $3.27 |
52-Week Low | $38.75 | $2.30 |
Enterprise Value | $5.47B | $341.13M |
Dividend Yield | 1.89% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Advance Auto Parts, Inc.
Advance Auto Parts is one of the industry's largest retailers of aftermarket automotive parts, tools, and accessories to do-it-yourself customers in North America. Advance operated 4,972 stores as of the end of 2021, in addition to servicing 1,317 independently owned Carquest stores. The company's Worldpac unit is a premier distributor of imported original-equipment parts. Advance derived 58% of its 2021 sales from commercial clients, up from 30%-40% before the General Parts deal.
Read more on AAP →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
